BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18068445)

  • 1. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma.
    Webster WS; Thompson RH; Cheville JC; Lohse CM; Blute ML; Leibovich BC
    Urology; 2007 Nov; 70(5):900-4; discussion 904. PubMed ID: 18068445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion.
    Thompson RH; Blute ML; Krambeck AE; Lohse CM; Magera JS; Leibovich BC; Kwon ED; Frank I; Cheville JC
    Am J Surg Pathol; 2007 Jul; 31(7):1089-93. PubMed ID: 17592276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
    Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
    J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Blute ML; Cheville JC; Lohse CM; Frank I; Kwon ED; Weaver AL; Parker AS; Zincke H
    Cancer; 2003 Apr; 97(7):1663-71. PubMed ID: 12655523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
    Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
    Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management.
    Margulis V; Sánchez-Ortiz RF; Tamboli P; Cohen DD; Swanson DA; Wood CG
    Cancer; 2007 May; 109(10):2025-30. PubMed ID: 17420980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival.
    Webster WS; Lohse CM; Thompson RH; Dong H; Frigola X; Dicks DL; Sengupta S; Frank I; Leibovich BC; Blute ML; Cheville JC; Kwon ED
    Cancer; 2006 Jul; 107(1):46-53. PubMed ID: 16708355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological outcomes of hand-assisted laparoscopic radical nephrectomy for clinically localized renal cell carcinoma: a single-institution study with >or=3 years of follow-up.
    Bandi G; Christian MW; Hedican SP; Moon TD; Nakada SY
    BJU Int; 2008 Feb; 101(4):459-62. PubMed ID: 17941924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.
    Jeong IG; Jeong CW; Hong SK; Kwak C; Lee E; Lee SE
    Urology; 2006 Apr; 67(4):709-12. PubMed ID: 16566981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
    J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.